Home

PB Ratio of Sun Pharma Advanced Research Company Ltd

Image

Sun Pharma Advanced Research Company Ltd

NSE: SPARC

PB Ratio

-

Last updated on: Dec 01, 2025

Key Highlights

  • The latest PB Ratio of Sun Pharma Advanced Research Company Ltd is 0.
  • The PB ratio of the Sun Pharma Advanced Research Company Ltd is below 1 which indicates that the stock is undervalued.
  • The P/B Ratio of Sun Pharma Advanced Research Company Ltd changed from 11.4 on March 2023 to -22.2 on March 2025 . This represents a CAGR of NaN% over 3 years.

Historical P/B Ratio of Sun Pharma Advanced Research Company Ltd

No data available

Company Fundamentals for Sun Pharma Advanced Research Company Ltd

Market Cap

4,356 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

0.0

Day’s High

145.95

Day’s Low

134.3

DTE

-1.2

ROE

77.5

52 Week High

240.95

52 Week Low

109.2

ROCE

-181.7

Market Price of Sun Pharma Advanced Research Company Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharma Advanced Research Company Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
01 Dec 2025134.25
28 Nov 2025134.4
27 Nov 2025136.1
26 Nov 2025133.5
25 Nov 2025133.05
24 Nov 2025133.55
21 Nov 2025135.95
20 Nov 2025138.25
19 Nov 2025130.8
18 Nov 2025130

SWOT Analysis Of Sun Pharma Advanced Research Company Ltd

Strength

1

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Sun Pharma Advanced Research Company Ltd

Asset Value vs Market Value of Sun Pharma Advanced Research Company Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PB Ratio of Sun Pharma Advanced Research Company Ltd Explained

4356

Market cap

-11

Book Value per Share

0.0X

PB Ratio

Historical Market Cap of Sun Pharma Advanced Research Company Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Sun Pharma Advanced Research Company Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Sun Pharma Advanced Research Company Ltd News Hub

Sun Pharma Advanced Research Company reports consolidated net loss of Rs 95.90 crore in the June 2024 quarter

Net Loss of Sun Pharma Advanced Research Company reported to Rs 95.90 crore in the quarter ended Jun

Read more

05 Aug 24

Sun Pharma Advanced Research Company reports consolidated net loss of Rs 107.33 crore in the September 2024 quarter

Net Loss of Sun Pharma Advanced Research Company reported to Rs 107.33 crore in the quarter ended Se

Read more

04 Nov 24

Sun Pharma Advanced Research Company to convene board meeting

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on

Read more

25 Oct 24

SPARC drops as Q2 net loss widens to Rs 107 crore

Net sales declined 39.29% year on year (YoY) to 12.86 crore in the quarter ended 30 September 2024.

Read more

04 Nov 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Sun Pharma Advanced Research Company Ltd

What is the PB ratio of Sun Pharma Advanced Research Company Ltd?

The current PB ratio of Sun Pharma Advanced Research Company Ltd is 0.0. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Sun Pharma Advanced Research Company Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Sun Pharma Advanced Research Company Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Sun Pharma Advanced Research Company Ltd calculated?

The PB ratio of Sun Pharma Advanced Research Company Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Sun Pharma Advanced Research Company Ltd?

A high PB ratio suggests that Sun Pharma Advanced Research Company Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Sun Pharma Advanced Research Company Ltd?

A low PB ratio of Sun Pharma Advanced Research Company Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Sun Pharma Advanced Research Company Ltd PB Ratio change over time?

Yes, the PB ratio of Sun Pharma Advanced Research Company Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions